Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer

BACKGROUND: The aim of this study was to evaluate the usefulness of the presence of malignant pleural effusion (MPE) as a negative predictor of anti‐PD‐1 antibody efficacy. METHODS: A retrospective review of patients with advanced or recurrent non‐small cell lung cancer treated with an anti‐PD‐1 ant...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Thorac Cancer
Hlavní autoři: Shibaki, Ryota, Murakami, Shuji, Shinno, Yuki, Matsumoto, Yuji, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Motoi, Noriko, Yamamoto, Noboru, Ohe, Yuichiro
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons Australia, Ltd 2019
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6449236/
https://ncbi.nlm.nih.gov/pubmed/30762312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13004
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky